Vertex Pharmaceuticals
VRTX
VRTX
1,066 hedge funds and large institutions have $60.7B invested in Vertex Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 150 funds opening new positions, 414 increasing their positions, 372 reducing their positions, and 102 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more funds holding
Funds holding: 1,028 → 1,066 (+38)
1.84% more ownership
Funds ownership: 90.53% → 92.36% (+1.8%)
32% less call options, than puts
Call options by funds: $591M | Put options by funds: $867M
Holders
1,066
Holding in Top 10
24
Calls
$591M
Puts
$867M
Top Buyers
| 1 | +$1.07B | |
| 2 | +$401M | |
| 3 | +$299M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$168M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$149M |
Top Sellers
| 1 | -$496M | |
| 2 | -$139M | |
| 3 | -$132M | |
| 4 |
Jennison Associates
New York
|
-$113M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$107M |